Moderate and high disease activity levels increase the risk of subclinical atherosclerosis progression in early rheumatoid arthritis: a 5-year prospective study.
Huan MengIsaac T ChengBryan Ping Yen YanAlex P LeeHo SoLai Shan TamPublished in: RMD open (2024)
Achieving persistent LDA or remission may prevent progression of atherosclerosis in ERA. A treat-to-target approach aiming at sustained LDA or remission may reduce the risk of CVD by preventing AP+.